188 related articles for article (PubMed ID: 23354002)
1. Central inhibition of interleukin-6 trans-signaling during peripheral infection reduced neuroinflammation and sickness in aged mice.
Burton MD; Rytych JL; Freund GG; Johnson RW
Brain Behav Immun; 2013 May; 30():66-72. PubMed ID: 23354002
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of interleukin-6 trans-signaling in the brain facilitates recovery from lipopolysaccharide-induced sickness behavior.
Burton MD; Sparkman NL; Johnson RW
J Neuroinflammation; 2011 May; 8():54. PubMed ID: 21595956
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6 trans-signaling in the senescent mouse brain is involved in infection-related deficits in contextual fear conditioning.
Burton MD; Johnson RW
Brain Behav Immun; 2012 Jul; 26(5):732-8. PubMed ID: 22062497
[TBL] [Abstract][Full Text] [Related]
4. Different Soluble Forms of the Interleukin-6 Family Signal Transducer gp130 Fine-tune the Blockade of Interleukin-6 Trans-signaling.
Wolf J; Waetzig GH; Chalaris A; Reinheimer TM; Wege H; Rose-John S; Garbers C
J Biol Chem; 2016 Jul; 291(31):16186-96. PubMed ID: 27226573
[TBL] [Abstract][Full Text] [Related]
5. Microglia priming by interleukin-6 signaling is enhanced in aged mice.
Garner KM; Amin R; Johnson RW; Scarlett EJ; Burton MD
J Neuroimmunol; 2018 Nov; 324():90-99. PubMed ID: 30261355
[TBL] [Abstract][Full Text] [Related]
6. Structure-guided optimization of the interleukin-6 trans-signaling antagonist sgp130.
Tenhumberg S; Waetzig GH; Chalaris A; Rabe B; Seegert D; Scheller J; Rose-John S; Grötzinger J
J Biol Chem; 2008 Oct; 283(40):27200-7. PubMed ID: 18650419
[TBL] [Abstract][Full Text] [Related]
7. Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia.
Henry CJ; Huang Y; Wynne A; Hanke M; Himler J; Bailey MT; Sheridan JF; Godbout JP
J Neuroinflammation; 2008 May; 5():15. PubMed ID: 18477398
[TBL] [Abstract][Full Text] [Related]
8. IL-6 trans-signaling system in intra-amniotic inflammation, preterm birth, and preterm premature rupture of the membranes.
Lee SY; Buhimschi IA; Dulay AT; Ali UA; Zhao G; Abdel-Razeq SS; Bahtiyar MO; Thung SF; Funai EF; Buhimschi CS
J Immunol; 2011 Mar; 186(5):3226-36. PubMed ID: 21282511
[TBL] [Abstract][Full Text] [Related]
9. Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1beta and anti-inflammatory IL-10 cytokines.
Henry CJ; Huang Y; Wynne AM; Godbout JP
Brain Behav Immun; 2009 Mar; 23(3):309-17. PubMed ID: 18814846
[TBL] [Abstract][Full Text] [Related]
10. Minimal interleukin 6 (IL-6) receptor stalk composition for IL-6 receptor shedding and IL-6 classic signaling.
Baran P; Nitz R; Grötzinger J; Scheller J; Garbers C
J Biol Chem; 2013 May; 288(21):14756-68. PubMed ID: 23564454
[TBL] [Abstract][Full Text] [Related]
11. The balance of interleukin (IL)-6, IL-6·soluble IL-6 receptor (sIL-6R), and IL-6·sIL-6R·sgp130 complexes allows simultaneous classic and trans-signaling.
Baran P; Hansen S; Waetzig GH; Akbarzadeh M; Lamertz L; Huber HJ; Ahmadian MR; Moll JM; Scheller J
J Biol Chem; 2018 May; 293(18):6762-6775. PubMed ID: 29559558
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of classic signaling is a novel function of soluble glycoprotein 130 (sgp130), which is controlled by the ratio of interleukin 6 and soluble interleukin 6 receptor.
Garbers C; Thaiss W; Jones GW; Waetzig GH; Lorenzen I; Guilhot F; Lissilaa R; Ferlin WG; Grötzinger J; Jones SA; Rose-John S; Scheller J
J Biol Chem; 2011 Dec; 286(50):42959-70. PubMed ID: 21990364
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1β signaling in fenestrated capillaries is sufficient to trigger sickness responses in mice.
Knoll JG; Krasnow SM; Marks DL
J Neuroinflammation; 2017 Nov; 14(1):219. PubMed ID: 29121947
[TBL] [Abstract][Full Text] [Related]
14. Involvement of Spinal IL-6 Trans-Signaling in the Induction of Hyperexcitability of Deep Dorsal Horn Neurons by Spinal Tumor Necrosis Factor-Alpha.
König C; Morch E; Eitner A; Möller C; Turnquist B; Schaible HG; Ebersberger A
J Neurosci; 2016 Sep; 36(38):9782-91. PubMed ID: 27656018
[TBL] [Abstract][Full Text] [Related]
15. Age-related increased prevalence of asthma and nasal polyps in chronic rhinosinusitis and its association with altered IL-6 trans-signaling.
Cho SH; Kim DW; Lee SH; Kolliputi N; Hong SJ; Suh L; Norton J; Hulse KE; Seshadri S; Conley DB; Kern RC; Tan BK; Peters A; Grammer LC; Schleimer RP
Am J Respir Cell Mol Biol; 2015 Nov; 53(5):601-6. PubMed ID: 26266960
[TBL] [Abstract][Full Text] [Related]
16. Influence of humanized anti-IL-6R antibody, tocilizumab on the activity of soluble gp130, natural inhibitor of IL-6 signaling.
Hashizume M; Mihara M
Rheumatol Int; 2009 Feb; 29(4):397-401. PubMed ID: 18802703
[TBL] [Abstract][Full Text] [Related]
17. Exploratory assessment of the effect of systemic administration of soluble glycoprotein 130 on cognitive performance and chemokine levels in a mouse model of experimental traumatic brain injury.
Gober IG; Russell AL; Shick TJ; Vagni VA; Carlson JC; Kochanek PM; Wagner AK
J Neuroinflammation; 2024 Jun; 21(1):149. PubMed ID: 38840141
[TBL] [Abstract][Full Text] [Related]
18. IL-6 trans-signaling is another pathway to upregulate Osteopontin.
Uchibori T; Matsuda K; Shimodaira T; Sugano M; Uehara T; Honda T
Cytokine; 2017 Feb; 90():88-95. PubMed ID: 27863335
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 and its receptors: a highly regulated and dynamic system.
Wolf J; Rose-John S; Garbers C
Cytokine; 2014 Nov; 70(1):11-20. PubMed ID: 24986424
[TBL] [Abstract][Full Text] [Related]
20. Trans-signaling is a dominant mechanism for the pathogenic actions of interleukin-6 in the brain.
Campbell IL; Erta M; Lim SL; Frausto R; May U; Rose-John S; Scheller J; Hidalgo J
J Neurosci; 2014 Feb; 34(7):2503-13. PubMed ID: 24523541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
